• Skip to main content

UTCardiothoracicSurgery.com

Heart conditions, cardiac medicines and supplements: what the evidence says on safety

  • Heart Meds
  • Blood Sugar
  • Weight Loss
  • Men’s Health
  • About

Clubhouse Bold Review 2026: Warfarin and Clopidogrel Interaction Risks

posted on September 12, 2026

By UTCardiothoracicSurgery.com Editorial Team

This article is for informational and educational purposes only and does not constitute medical advice. Consult your physician before starting any supplement, particularly if you have a cardiovascular condition or take prescription medications. UTCardiothoracicSurgery.com Editorial Team | January 2026.

This article may contain affiliate links. If you purchase through a link in this article, a commission may be earned at no additional cost to you. This does not affect the objectivity of the information presented.

Cardiac Safety Summary: Clubhouse Bold

  • Product Type: Dietary supplement (capsule format)
  • Key Ingredients: Not verified from independent label review; proprietary blend claimed
  • Price Range: Not disclosed
  • Refund Policy: Not verified
  • Cardiac Drug Interactions: Potential concern with blood thinners and antiplatelet agents if proprietary blend contains coagulation-active herbs; full ingredient transparency required for safe assessment
  • Quick Answer: Clubhouse Bold is marketed as a general wellness supplement, but this review found significant label transparency gaps that prevent independent cardiac safety assessment. Readers with cardiovascular conditions and those on anticoagulants should request full ingredient disclosure and consult their cardiologist before use.

What Makes This Review Different: Why Cardiac Patients Need Ingredient Clarity

General wellness reviews of Clubhouse Bold focus on marketing appeal and broad health claims, but they typically overlook a critical gap for cardiac patients: ingredient transparency and drug interaction risk. This review prioritizes what cardiologists need to know. Readers taking warfarin, dabigatran, rivaroxaban, or dual antiplatelet therapy (aspirin + clopidogrel) face real clinical risk if they unknowingly consume ingredients that thin blood, lower blood pressure, or interact with their current medications.

Unlike typical supplement reviews that treat all consumers identically, this analysis evaluates Clubhouse Bold specifically through the lens of a patient managing hypertension, atrial fibrillation, coronary artery disease, or post-stent recovery. The core question: Can a cardiac patient safely use this product alongside their existing regimen? That requires knowing exactly what's in the bottle.

What Clubhouse Bold Is: Verified Product Summary

According to available information, Clubhouse Bold is a dietary supplement sold in capsule format, marketed for general wellness and vitality. The product is not independently verified to contain a published Supplement Facts panel accessible through standard FDA or third-party lab databases at this time. Manufacturer details, serving size guidance, and explicit suggested-use instructions are not verified from primary sources in this review.

The product name suggests positioning within the “bold wellness” or “confidence-building” supplement category, a market segment that often blends traditional botanicals with contemporary wellness messaging. Without access to an independently verified label, this review cannot confirm the actual capsule count per container, ingredient weights, or specific formulation details. Readers should request a complete Supplement Facts panel directly from the retailer before purchase, as this is standard due diligence for any cardiac patient considering a new supplement.

The Label vs. Marketing Analysis: Transparency Gaps and Disclosure Concerns

This review encountered a significant barrier: a publicly available, verifiable Supplement Facts label for Clubhouse Bold could not be independently located or confirmed. This is a red flag in itself. When a supplement lacks transparent labeling or accessible ingredient disclosure, cardiac patients cannot perform informed risk assessment.

Marketing language for products in this category often emphasizes confidence, social presence, or energy without specifying the bioactive compounds responsible for those effects. The absence of dose transparency creates a secondary concern: cardiac patients cannot compare label doses to clinical research doses, a critical step in assessing safety. For example, if Clubhouse Bold contains botanicals like ginseng, hawthorn, or ginkgo biloba—all common in “bold” or vitality-focused formulas—the clinical dose in published trials ranges from 150 mg to 900+ mg per ingredient, depending on the study.

A proprietary blend listing “Vitality Complex (250 mg)” reveals nothing about the dose of each ingredient, meaning a cardiac patient cannot evaluate whether the amount is therapeutic, sub-therapeutic, or potentially risky in combination with medications like beta-blockers or ACE inhibitors. Until full ingredient transparency is provided, claims of safety cannot be substantiated.

Clubhouse Bold Ingredient Evidence and Dose Analysis

Without a verified, independently accessible label, this review cannot identify specific ingredients or their doses in Clubhouse Bold with certainty. However, products marketed with similar positioning (“bold,” “vitality,” “social confidence”) typically include one or more of the following: ginseng (Panax ginseng or Panax quinquefolius), ginkgo biloba, guarana, L-theanine, B vitamins, or herbal adaptogens like rhodiola or ashwagandha. Each carries distinct clinical evidence and interaction profiles.

For example, ginseng has moderate evidence for cognitive function and fatigue in some studies (typical doses: 200–400 mg daily in clinical trials), but it also has documented interactions with warfarin and can potentiate antiplatelet effects. Ginkgo biloba shows mixed evidence for cognitive support and has a well-known bleeding risk when combined with anticoagulants or antiplatelet drugs at doses above 240 mg daily. Guarana is a caffeine source (roughly 40–50 mg caffeine per gram of guarana powder) and may elevate heart rate and blood pressure, a concern for patients with arrhythmias or uncontrolled hypertension.

L-theanine, an amino acid from green tea, has limited interaction risk but minimal evidence for the specific “boldness” or social claims often marketed. Without knowing which ingredients Clubhouse Bold contains and in what amounts, readers cannot independently assess whether doses align with published clinical research or fall into a sub-therapeutic range where efficacy is unlikely but risk persists.

Clubhouse Bold Cardiac Safety Profile: Drug Interactions and Risk Assessment

Cardiac patients face specific interaction risks with supplements marketed for energy, confidence, or social vigor—precisely because these products often contain stimulants, herbs that affect coagulation, or compounds that lower blood pressure unpredictably. For readers on anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran, edoxaban), the absence of ingredient transparency in Clubhouse Bold is particularly concerning. If the formula contains ginkgo biloba, ginseng, turmeric, or other botanical anticoagulants, the cumulative effect with prescription anticoagulation could increase bleeding risk.

A patient on warfarin with a therapeutic INR of 2.0–3.0 who unknowingly adds a ginkgo-containing supplement may shift that range upward, increasing the risk of gastrointestinal bleeding, intracranial hemorrhage, or other serious events. For readers on beta-blockers (metoprolol, atenolol, carvedilol) or calcium channel blockers (amlodipine, diltiazem), stimulant ingredients like guarana or high-dose caffeine can counteract blood pressure and heart rate control, potentially triggering tachycardia or palpitations. Patients with atrial fibrillation are at particular risk.

For those on ACE inhibitors or ARBs (lisinopril, losartan), some adaptogenic herbs may cause unexpected blood pressure drops when combined, leading to dizziness, syncope, or reduced renal perfusion. Until Clubhouse Bold provides full ingredient disclosure, cardiac patients cannot perform this risk-benefit analysis with their physician. This is not a flaw in the product alone—it is a barrier to informed use.

Clubhouse Bold User-Reported Outcomes: Limited Independent Data

User reviews and reported outcomes for Clubhouse Bold are not independently verified through this analysis. Without access to a dedicated product page with aggregated third-party reviews, claims about efficacy, side effects, or user satisfaction cannot be documented. Consumer testimonials on supplement retailer sites often lack demographic data (age, comorbidities, medication use) and are not verified for authenticity.

For cardiac patients, anecdotal reports of increased energy or improved mood are insufficient safety signals—a product may feel effective while silently increasing bleeding risk or destabilizing heart rhythm in vulnerable individuals. Rigorous, long-term clinical trials in cardiac populations would be required to substantiate claims; such data is not available for products in this category.

Pricing and Refund Terms: Limited Information

Specific pricing for Clubhouse Bold, cost per serving, and refund policy details are not verified through this review. Pricing for similar supplement products typically ranges from $20 to $60 per month supply, depending on bottle size and retail channel. Refund policies vary widely; some manufacturers offer 30-day or 60-day money-back is designed to deliver, while others do not.

Readers should request current pricing and refund details directly from the official retailer and confirm the start date of any refund window and whether return shipping is covered. Pricing is subject to change. Verify current pricing on the manufacturer's official listing.

Clubhouse Bold for Cardiac Patients: Who Should Consider It, Who Should Avoid It

The evidence base for Clubhouse Bold does not support recommendations for cardiac patients at this time, primarily because ingredient transparency is insufficient for safe risk assessment. Readers without cardiovascular disease or medication interactions may view general wellness supplements with less clinical urgency; however, the lack of labeling transparency is a broader quality and regulatory concern. For cardiac patients specifically—those with a history of myocardial infarction, stroke, atrial fibrillation, heart failure, or those on anticoagulants, antiplatelet agents, antiarrhythmics, or blood pressure medications—this product should not be used without (1) full ingredient disclosure from the manufacturer, (2) a letter from the cardiologist confirming no interactions, and (3) baseline INR testing if the patient is on warfarin, with follow-up testing after 2–4 weeks to detect any drift.

Patients should be particularly cautious if they have uncontrolled hypertension, recent coronary stent placement, or symptomatic arrhythmias. The responsible path forward is not to accept marketing claims or proceed based on general wellness narratives, but to demand transparency and clinical evidence aligned with cardiac safety standards.

What Questions Remain Unanswered About Clubhouse Bold

This review identified critical gaps that should be addressed before cardiac patients consider use: (1) What are the exact ingredients and their doses? (2) Has Clubhouse Bold been tested for contaminants (heavy metals, microbial pathogens)? (3) Are there published clinical trials in human subjects, or is efficacy based on in-vitro or animal research alone? (4) Has the manufacturer conducted any cardiac safety studies or drug interaction testing? (5) Are there reported adverse events in cardiac populations? (6) Does the manufacturer test batches for potency and purity consistency? (7) What is the mechanism by which the proprietary blend claims to support “boldness” or confidence, and is that mechanism cardiac-relevant? Until these questions are answered with verifiable, transparent data, cardiac patients should treat Clubhouse Bold as an unproven supplement with unknown interaction potential rather than a safe wellness addition.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and does not constitute medical advice.

Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.

Related Reading on UT Cardiothoracic Surgery

  • PDE5 Inhibitors and Blood Pressure Medications: Drug Interactions Every Man on Cardiac Meds Should Understand
  • Compounded ED Combinations and Heart Medications: Nitrates, Blood Pressure, and Cardiac Safety
  • HorseWood Cardiac Safety Review 2026: Medication Questions to Check First

Further reading

  1. Clubhouse Stud Review
  2. uChews Review
  3. Red Boost Review
  4. Hunter Burn Review

Filed Under: Men's Vitality

UTCardiothoracicSurgery.com

A health and wellness editorial publication operated by UTCTS Health Review.

Topics

  • GLP-1 Medications
  • Telehealth
  • Weight Loss
  • Supplements
  • Brain & Nerve Health
  • Anti-Aging
  • Men’s Vitality
  • Blood Sugar

Publication

  • About
  • How We Review
  • Editorial Standards
  • Contact

Policies

  • Medical Disclaimer
  • Privacy Policy
  • Terms of Use
  • Affiliate Disclosure

Not medical advice. UTCTS Health Review is an editorial publication, not a medical practice. Some links earn us a commission at no cost to you.

Not affiliated with UT Health San Antonio, its Department of Cardiothoracic Surgery or the University of Texas System. For patient care, visit lsom.uthscsa.edu/ct-surgery.

© 2026 UTCardiothoracicSurgery.com · UTCTS Health Review